<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="198">
<accession>Q14118</accession>
<accession>A8K6M7</accession>
<accession>Q969J9</accession>
<name>DAG1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Dystroglycan</fullName>
</recommendedName>
<alternativeName>
<fullName>Dystrophin-associated glycoprotein 1</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Alpha-dystroglycan</fullName>
<shortName>Alpha-DG</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Beta-dystroglycan</fullName>
<shortName>Beta-DG</shortName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">DAG1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Hum. Mol. Genet." volume="2" first="1651" last="1657">
<title>Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization.</title>
<authorList>
<person name="Ibraghimov-Beskrovnaya O."/>
<person name="Milatovich A."/>
<person name="Ozcelik T."/>
<person name="Yang B."/>
<person name="Koepnick K."/>
<person name="Francke U."/>
<person name="Campbell K.P."/>
</authorList>
<dbReference type="PubMed" id="8268918"/>
<dbReference type="DOI" id="10.1093/hmg/2.10.1651"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT TRP-14</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT TRP-14</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT TRP-14</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT TRP-14</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="27305" last="27310">
<title>Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.</title>
<authorList>
<person name="Jung D."/>
<person name="Yang B."/>
<person name="Meyer J."/>
<person name="Chamberlain J.S."/>
<person name="Campbell K.P."/>
</authorList>
<dbReference type="PubMed" id="7592992"/>
<dbReference type="DOI" id="10.1074/jbc.270.45.27305"/>
</citation>
<scope>INTERACTION WITH DMD</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Science" volume="282" first="2076" last="2079">
<title>Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae.</title>
<authorList>
<person name="Rambukkana A."/>
<person name="Yamada H."/>
<person name="Zanazzi G."/>
<person name="Mathus T."/>
<person name="Salzer J.L."/>
<person name="Yurchenco P.D."/>
<person name="Campbell K.P."/>
<person name="Fischetti V.A."/>
</authorList>
<dbReference type="PubMed" id="9851927"/>
<dbReference type="DOI" id="10.1126/science.282.5396.2076"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION) AS RECEPTOR FOR MYCOBACTERIUM LEPRAE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH LAMA2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="FEBS Lett." volume="471" first="229" last="234">
<title>Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex.</title>
<authorList>
<person name="Tommasi di Vignano A."/>
<person name="Di Zenzo G."/>
<person name="Sudol M."/>
<person name="Cesareni G."/>
<person name="Dente L."/>
</authorList>
<dbReference type="PubMed" id="10767429"/>
<dbReference type="DOI" id="10.1016/s0014-5793(00)01400-9"/>
</citation>
<scope>INTERACTION WITH UTRN</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="38048" last="38058">
<title>Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.</title>
<authorList>
<person name="Sotgia F."/>
<person name="Lee J.K."/>
<person name="Das K."/>
<person name="Bedford M."/>
<person name="Petrucci T.C."/>
<person name="Macioce P."/>
<person name="Sargiacomo M."/>
<person name="Bricarelli F.D."/>
<person name="Minetti C."/>
<person name="Sudol M."/>
<person name="Lisanti M.P."/>
</authorList>
<dbReference type="PubMed" id="10988290"/>
<dbReference type="DOI" id="10.1074/jbc.m005321200"/>
</citation>
<scope>INTERACTION WITH CAV3</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Cell Sci." volume="113" first="1717" last="1726">
<title>Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin.</title>
<authorList>
<person name="James M."/>
<person name="Nuttall A."/>
<person name="Ilsley J.L."/>
<person name="Ottersbach K."/>
<person name="Tinsley J.M."/>
<person name="Sudol M."/>
<person name="Winder S.J."/>
</authorList>
<dbReference type="PubMed" id="10769203"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH UTRN</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Biochemistry" volume="40" first="14585" last="14592">
<title>Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins.</title>
<authorList>
<person name="Sotgia F."/>
<person name="Lee H."/>
<person name="Bedford M.T."/>
<person name="Petrucci T."/>
<person name="Sudol M."/>
<person name="Lisanti M.P."/>
</authorList>
<dbReference type="PubMed" id="11724572"/>
<dbReference type="DOI" id="10.1021/bi011247r"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH FYN; CSK; NCK AND SHC</scope>
<scope>POSSIBLE FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="Cell. Signal." volume="13" first="625" last="632">
<title>The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation.</title>
<authorList>
<person name="Ilsley J.L."/>
<person name="Sudol M."/>
<person name="Winder S.J."/>
</authorList>
<dbReference type="PubMed" id="11495720"/>
<dbReference type="DOI" id="10.1016/s0898-6568(01)00188-7"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-892</scope>
<scope>INTERACTION WITH DMD</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Nature" volume="418" first="417" last="422">
<title>Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.</title>
<authorList>
<person name="Michele D.E."/>
<person name="Barresi R."/>
<person name="Kanagawa M."/>
<person name="Saito F."/>
<person name="Cohn R.D."/>
<person name="Satz J.S."/>
<person name="Dollar J."/>
<person name="Nishino I."/>
<person name="Kelley R.I."/>
<person name="Somer H."/>
<person name="Straub V."/>
<person name="Mathews K.D."/>
<person name="Moore S.A."/>
<person name="Campbell K.P."/>
</authorList>
<dbReference type="PubMed" id="12140558"/>
<dbReference type="DOI" id="10.1038/nature00837"/>
</citation>
<scope>GLYCOSYLATION</scope>
<scope>LIGAND-BINDING</scope>
<scope>ASSOCIATION WITH CONGENITAL MUSCULAR DYSTROPHIES</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="7110" last="7123">
<title>Localization of phospho-beta-dystroglycan (pY892) to an intracellular vesicular compartment in cultured cells and skeletal muscle fibers in vivo.</title>
<authorList>
<person name="Sotgia F."/>
<person name="Bonuccelli G."/>
<person name="Bedford M."/>
<person name="Brancaccio A."/>
<person name="Mayer U."/>
<person name="Wilson M.T."/>
<person name="Campos-Gonzalez R."/>
<person name="Brooks J.W."/>
<person name="Sudol M."/>
<person name="Lisanti M.P."/>
</authorList>
<dbReference type="PubMed" id="12795607"/>
<dbReference type="DOI" id="10.1021/bi0271289"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-892</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-892</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Br. J. Cancer" volume="88" first="579" last="585">
<title>hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan.</title>
<authorList>
<person name="Fletcher G.C."/>
<person name="Patel S."/>
<person name="Tyson K."/>
<person name="Adam P.J."/>
<person name="Schenker M."/>
<person name="Loader J.A."/>
<person name="Daviet L."/>
<person name="Legrain P."/>
<person name="Parekh R."/>
<person name="Harris A.L."/>
<person name="Terrett J.A."/>
</authorList>
<dbReference type="PubMed" id="12592373"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6600740"/>
</citation>
<scope>INTERACTION WITH AGR2 AND AGR3</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Invest. Dermatol." volume="122" first="1372" last="1380">
<title>Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface.</title>
<authorList>
<person name="Herzog C."/>
<person name="Has C."/>
<person name="Franzke C.W."/>
<person name="Echtermeyer F.G."/>
<person name="Schlotzer-Schrehardt U."/>
<person name="Kroger S."/>
<person name="Gustafsson E."/>
<person name="Fassler R."/>
<person name="Bruckner-Tuderman L."/>
</authorList>
<dbReference type="PubMed" id="15175026"/>
<dbReference type="DOI" id="10.1111/j.0022-202x.2004.22605.x"/>
</citation>
<scope>PROTEOLYTIC PROCESSING OF THE BETA SUBUNIT</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Virol." volume="79" first="14297" last="14308">
<title>O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.</title>
<authorList>
<person name="Imperiali M."/>
<person name="Thoma C."/>
<person name="Pavoni E."/>
<person name="Brancaccio A."/>
<person name="Callewaert N."/>
<person name="Oxenius A."/>
</authorList>
<dbReference type="PubMed" id="16254364"/>
<dbReference type="DOI" id="10.1128/jvi.79.22.14297-14308.2005"/>
</citation>
<scope>GLYCOSYLATION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH LYMPHOCYCTIC CHORIOMENINGITIS VIRUS GLYCOPROTEIN</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Genes Cells" volume="12" first="75" last="88">
<title>Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association.</title>
<authorList>
<person name="Watanabe N."/>
<person name="Sasaoka T."/>
<person name="Noguchi S."/>
<person name="Nishino I."/>
<person name="Tanaka T."/>
</authorList>
<dbReference type="PubMed" id="17212656"/>
<dbReference type="DOI" id="10.1111/j.1365-2443.2006.01033.x"/>
</citation>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="J. Virol." volume="81" first="5685" last="5695">
<title>Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands.</title>
<authorList>
<person name="Rojek J.M."/>
<person name="Spiropoulou C.F."/>
<person name="Campbell K.P."/>
<person name="Kunz S."/>
</authorList>
<dbReference type="PubMed" id="17360738"/>
<dbReference type="DOI" id="10.1128/jvi.02574-06"/>
</citation>
<scope>GLYCOSYLATION</scope>
<scope>FUNCTION (MICROBIAL INFECTION) AS RECEPTOR FOR OLD WORLD AND CLADE C NEW WORLD ARENAVIRUSES</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="FASEB J." volume="22" first="612" last="621">
<title>SEA domain proteolysis determines the functional composition of dystroglycan.</title>
<authorList>
<person name="Akhavan A."/>
<person name="Crivelli S.N."/>
<person name="Singh M."/>
<person name="Lingappa V.R."/>
<person name="Muschler J.L."/>
</authorList>
<dbReference type="PubMed" id="17905726"/>
<dbReference type="DOI" id="10.1096/fj.07-8354com"/>
</citation>
<scope>AUTOCATALYTIC CLEAVAGE AT GLY-653</scope>
<scope>GLYCOSYLATION</scope>
<scope>LIGAND-BINDING</scope>
<scope>MUTAGENESIS OF SER-654</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Traffic" volume="9" first="2063" last="2072">
<title>Nuclear translocation of beta-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucins.</title>
<authorList>
<person name="Oppizzi M.L."/>
<person name="Akhavan A."/>
<person name="Singh M."/>
<person name="Fata J.E."/>
<person name="Muschler J.L."/>
</authorList>
<dbReference type="PubMed" id="18764929"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2008.00822.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>GLYCOSYLATION AT ASN-661</scope>
<scope>MUTAGENESIS OF SER-654; THR-663; 777-LYS--LYS-780; 793-LYS-LYS-794; LYS-823; 828-PRO-PRO-829 AND TYR-831</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="IUBMB Life" volume="61" first="1143" last="1152">
<title>Enzymatic processing of beta-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site.</title>
<authorList>
<person name="Bozzi M."/>
<person name="Inzitari R."/>
<person name="Sbardell D."/>
<person name="Monaco S."/>
<person name="Pavoni E."/>
<person name="Gioia M."/>
<person name="Marini S."/>
<person name="Morlacchi S."/>
<person name="Sciandra F."/>
<person name="Castagnola M."/>
<person name="Giardina B."/>
<person name="Brancaccio A."/>
<person name="Coletta M."/>
</authorList>
<dbReference type="PubMed" id="19946898"/>
<dbReference type="DOI" id="10.1002/iub.273"/>
</citation>
<scope>PROTEOLYTIC PROCESSING OF BETA SUBUNIT</scope>
<scope>PROTEOLYTIC CLEAVAGE AT HIS-715</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Nat. Methods" volume="6" first="809" last="811">
<title>Enrichment of glycopeptides for glycan structure and attachment site identification.</title>
<authorList>
<person name="Nilsson J."/>
<person name="Rueetschi U."/>
<person name="Halim A."/>
<person name="Hesse C."/>
<person name="Carlsohn E."/>
<person name="Brinkmalm G."/>
<person name="Larson G."/>
</authorList>
<dbReference type="PubMed" id="19838169"/>
<dbReference type="DOI" id="10.1038/nmeth.1392"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS]</scope>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<source>
<tissue>Cerebrospinal fluid</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Virology" volume="387" first="245" last="249">
<title>Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction.</title>
<authorList>
<person name="Kunz S."/>
</authorList>
<dbReference type="PubMed" id="19324387"/>
<dbReference type="DOI" id="10.1016/j.virol.2009.02.042"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH LASSA VIRUS GLYCOPROTEIN</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Glycobiology" volume="20" first="1160" last="1169">
<title>Characterization of site-specific O-glycan structures within the mucin-like domain of {alpha}-dystroglycan from human skeletal muscle.</title>
<authorList>
<person name="Nilsson J."/>
<person name="Nilsson J."/>
<person name="Larson G."/>
<person name="Grahn A."/>
</authorList>
<dbReference type="PubMed" id="20507882"/>
<dbReference type="DOI" id="10.1093/glycob/cwq082"/>
</citation>
<scope>STRUCTURE OF CARBOHYDRATES</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>GLYCOSYLATION AT THR-367; THR-369; THR-372 AND THR-455</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="J. Cell. Biochem." volume="110" first="706" last="717">
<title>Characterization of an Importin alpha/beta-recognized nuclear localization signal in beta-dystroglycan.</title>
<authorList>
<person name="Lara-Chacon B."/>
<person name="de Leon M.B."/>
<person name="Leocadio D."/>
<person name="Gomez P."/>
<person name="Fuentes-Mera L."/>
<person name="Martinez-Vieyra I."/>
<person name="Ortega A."/>
<person name="Jans D.A."/>
<person name="Cisneros B."/>
</authorList>
<dbReference type="PubMed" id="20512930"/>
<dbReference type="DOI" id="10.1002/jcb.22581"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-892</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 777-LYS--LYS-782 AND TYR-892</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Science" volume="327" first="88" last="92">
<title>O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.</title>
<authorList>
<person name="Yoshida-Moriguchi T."/>
<person name="Yu L."/>
<person name="Stalnaker S.H."/>
<person name="Davis S."/>
<person name="Kunz S."/>
<person name="Madson M."/>
<person name="Oldstone M.B."/>
<person name="Schachter H."/>
<person name="Wells L."/>
<person name="Campbell K.P."/>
</authorList>
<dbReference type="PubMed" id="20044576"/>
<dbReference type="DOI" id="10.1126/science.1180512"/>
</citation>
<scope>GLYCOSYLATION AT THR-379; THR-381 AND THR-388</scope>
<scope>PHOSPHORYLATION AT THR-379</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="N. Engl. J. Med." volume="364" first="939" last="946">
<title>A dystroglycan mutation associated with limb-girdle muscular dystrophy.</title>
<authorList>
<person name="Hara Y."/>
<person name="Balci-Hayta B."/>
<person name="Yoshida-Moriguchi T."/>
<person name="Kanagawa M."/>
<person name="Beltran-Valero de Bernabe D."/>
<person name="Gundesli H."/>
<person name="Willer T."/>
<person name="Satz J.S."/>
<person name="Crawford R.W."/>
<person name="Burden S.J."/>
<person name="Kunz S."/>
<person name="Oldstone M.B."/>
<person name="Accardi A."/>
<person name="Talim B."/>
<person name="Muntoni F."/>
<person name="Topaloglu H."/>
<person name="Dincer P."/>
<person name="Campbell K.P."/>
</authorList>
<dbReference type="PubMed" id="21388311"/>
<dbReference type="DOI" id="10.1056/nejmoa1006939"/>
</citation>
<scope>INVOLVEMENT IN MDDGC9</scope>
<scope>VARIANT MDDGC9 MET-192</scope>
<scope>CHARACTERIZATION OF VARIANT MDDGC9 MET-192</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="17426" last="17431">
<title>Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.</title>
<authorList>
<person name="Hara Y."/>
<person name="Kanagawa M."/>
<person name="Kunz S."/>
<person name="Yoshida-Moriguchi T."/>
<person name="Satz J.S."/>
<person name="Kobayashi Y.M."/>
<person name="Zhu Z."/>
<person name="Burden S.J."/>
<person name="Oldstone M.B."/>
<person name="Campbell K.P."/>
</authorList>
<dbReference type="PubMed" id="21987822"/>
<dbReference type="DOI" id="10.1073/pnas.1114836108"/>
</citation>
<scope>GLYCOSYLATION AT THR-317 AND THR-319</scope>
<scope>PHOSPHORYLATION AT THR-317 AND THR-319</scope>
<scope>MUTAGENESIS OF 317-THR--THR-319 AND 328-THR-THR-329</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-790</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="573" last="584">
<title>LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins.</title>
<authorList>
<person name="Halim A."/>
<person name="Ruetschi U."/>
<person name="Larson G."/>
<person name="Nilsson J."/>
</authorList>
<dbReference type="PubMed" id="23234360"/>
<dbReference type="DOI" id="10.1021/pr300963h"/>
</citation>
<scope>GLYCOSYLATION AT THR-63</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Neurogenetics" volume="14" first="205" last="213">
<title>Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy.</title>
<authorList>
<person name="Geis T."/>
<person name="Marquard K."/>
<person name="Roedl T."/>
<person name="Reihle C."/>
<person name="Schirmer S."/>
<person name="von Kalle T."/>
<person name="Bornemann A."/>
<person name="Hehr U."/>
<person name="Blankenburg M."/>
</authorList>
<dbReference type="PubMed" id="24052401"/>
<dbReference type="DOI" id="10.1007/s10048-013-0374-9"/>
</citation>
<scope>INVOLVEMENT IN MDDGA9</scope>
<scope>VARIANT MDDGA9 PHE-669</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="Sci. Rep." volume="3" first="3288" last="3288">
<title>AGO61-dependent GlcNAc modification primes the formation of functional glycans on alpha-dystroglycan.</title>
<authorList>
<person name="Yagi H."/>
<person name="Nakagawa N."/>
<person name="Saito T."/>
<person name="Kiyonari H."/>
<person name="Abe T."/>
<person name="Toda T."/>
<person name="Wu S.W."/>
<person name="Khoo K.H."/>
<person name="Oka S."/>
<person name="Kato K."/>
</authorList>
<dbReference type="PubMed" id="24256719"/>
<dbReference type="DOI" id="10.1038/srep03288"/>
</citation>
<scope>GLYCOSYLATION AT THR-317 AND THR-319</scope>
<scope>PHOSPHORYLATION AT THR-317 AND THR-319</scope>
<scope>MUTAGENESIS OF 317-THR--THR-319</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-790</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2015" name="Neurology" volume="84" first="273" last="279">
<title>DAG1 mutations associated with asymptomatic hyperCKemia and hypoglycosylation of alpha-dystroglycan.</title>
<authorList>
<person name="Dong M."/>
<person name="Noguchi S."/>
<person name="Endo Y."/>
<person name="Hayashi Y.K."/>
<person name="Yoshida S."/>
<person name="Nonaka I."/>
<person name="Nishino I."/>
</authorList>
<dbReference type="PubMed" id="25503980"/>
<dbReference type="DOI" id="10.1212/wnl.0000000000001162"/>
</citation>
<scope>INVOLVEMENT IN MDDGC9</scope>
<scope>VARIANTS MDDGC9 ILE-74 AND ASN-111</scope>
<scope>CHARACTERIZATION OF VARIANTS MDDGC9 ILE-74 AND ASN-111</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Neurology" volume="84" first="2177" last="2182">
<title>Absence of alpha- and beta-dystroglycan is associated with Walker-Warburg syndrome.</title>
<authorList>
<person name="Riemersma M."/>
<person name="Mandel H."/>
<person name="van Beusekom E."/>
<person name="Gazzoli I."/>
<person name="Roscioli T."/>
<person name="Eran A."/>
<person name="Gershoni-Baruch R."/>
<person name="Gershoni M."/>
<person name="Pietrokovski S."/>
<person name="Vissers L.E."/>
<person name="Lefeber D.J."/>
<person name="Willemsen M.A."/>
<person name="Wevers R.A."/>
<person name="van Bokhoven H."/>
</authorList>
<dbReference type="PubMed" id="25934851"/>
<dbReference type="DOI" id="10.1212/wnl.0000000000001615"/>
</citation>
<scope>INVOLVEMENT IN MDDGA9</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2000" name="Nat. Struct. Biol." volume="7" first="634" last="638">
<title>Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.</title>
<authorList>
<person name="Huang X."/>
<person name="Poy F."/>
<person name="Zhang R."/>
<person name="Joachimiak A."/>
<person name="Sudol M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="10932245"/>
<dbReference type="DOI" id="10.1038/77923"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 881-895</scope>
</reference>
<reference key="39" evidence="1">
<citation type="journal article" date="2016" name="Proc. Natl. Acad. Sci. U.S.A." volume="113" first="9280" last="9285">
<title>Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of alpha-dystroglycan.</title>
<authorList>
<person name="Kuwabara N."/>
<person name="Manya H."/>
<person name="Yamada T."/>
<person name="Tateno H."/>
<person name="Kanagawa M."/>
<person name="Kobayashi K."/>
<person name="Akasaka-Manya K."/>
<person name="Hirose Y."/>
<person name="Mizuno M."/>
<person name="Ikeguchi M."/>
<person name="Toda T."/>
<person name="Hirabayashi J."/>
<person name="Senda T."/>
<person name="Endo T."/>
<person name="Kato R."/>
</authorList>
<dbReference type="PubMed" id="27493216"/>
<dbReference type="DOI" id="10.1073/pnas.1525545113"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 316-325 IN COMPLEX WITH POMGNT1</scope>
</reference>
<reference key="40" evidence="2">
<citation type="journal article" date="2017" name="FEBS Open Bio" volume="7" first="1064" last="1077">
<title>Structural flexibility of human alpha-dystroglycan.</title>
<authorList>
<person name="Covaceuszach S."/>
<person name="Bozzi M."/>
<person name="Bigotti M.G."/>
<person name="Sciandra F."/>
<person name="Konarev P.V."/>
<person name="Brancaccio A."/>
<person name="Cassetta A."/>
</authorList>
<dbReference type="PubMed" id="28781947"/>
<dbReference type="DOI" id="10.1002/2211-5463.12259"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 52-315</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text>The dystroglycan complex is involved in a number of processes including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, and epithelial polarization.</text>
</comment>
<comment type="function">
<molecule>Alpha-dystroglycan</molecule>
<text evidence="6">Extracellular peripheral glycoprotein that acts as a receptor for extracellular matrix proteins containing laminin-G domains. Receptor for laminin-2 (LAMA2) and agrin in peripheral nerve Schwann cells. Also acts as a receptor for laminin LAMA5 (By similarity).</text>
</comment>
<comment type="function">
<molecule>Beta-dystroglycan</molecule>
<text>Transmembrane protein that plays important roles in connecting the extracellular matrix to the cytoskeleton. Acts as a cell adhesion receptor in both muscle and non-muscle tissues. Receptor for both DMD and UTRN and, through these interactions, scaffolds axin to the cytoskeleton. Also functions in cell adhesion-mediated signaling and implicated in cell polarity.</text>
</comment>
<comment type="function">
<molecule>Alpha-dystroglycan</molecule>
<text evidence="21 23 26 43">(Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus glycoprotein and class C new-world arenaviruses (PubMed:16254364, PubMed:19324387, PubMed:17360738). Acts as a Schwann cell receptor for Mycobacterium leprae, the causative organism of leprosy, but only in the presence of the G-domain of LAMA2 (PubMed:9851927).</text>
</comment>
<comment type="subunit">
<text evidence="7 8 10 11 12 13 14 16 39 41">Monomer. Heterodimer of alpha- and beta-dystroglycan subunits which are the central components of the dystrophin-glycoprotein complex. This complex then can form a dystrophin-associated glycoprotein complex (DGC) which is composed of three subcomplexes: a cytoplasmic complex comprised of DMD (or UTRN), DTNA and a number of syntrophins, such as SNTB1, SNTB2, SNTG1 and SNTG2, the transmembrane dystroglycan complex, and the sarcoglycan-sarcospan complex. Interacts (via the N-terminal of alphaDAG1) with LARGE1; the interaction enhances laminin binding (By similarity). Interacts with SGCD. Interacts with AGR2 and AGR3. Interacts (betaDAG1) with DMD; the interaction is inhibited by phosphorylation on the PPXY motif. Interacts (betaDAG1, via its PPXY motif) with UTRN (via its WWW and ZZ domains); the interaction is inhibited by phosphorylation on the PPXY motif. Interacts (betaDAG1, via its phosphorylated PPXY motif) with the SH2 domain-containing proteins, FYN, CSK, NCK and SHC. Interacts (betaDAG1) with CAV3 (via a central WW-like domain); the interaction disrupts the binding of DMD. BetaDAG1 directly interacts with ANK3, but not with ANK2; this interaction does not interfere with DMD-binding and is required for retention at costameres (By similarity). Identified in a dystroglycan complex that contains at least PRX, DRP2, UTRN, DMD and DAG1 (By similarity). Interacts with POMGNT1 (PubMed:27493216).</text>
</comment>
<comment type="subunit">
<text evidence="21 26">(Microbial infection) Interacts with lassa virus and lymphocytic choriomeningitis virus glycoprotein (PubMed:16254364, PubMed:19324387).</text>
</comment>
<comment type="subunit">
<text evidence="43">(Microbial infection) Interacts with surface molecules of mycobacterium leprae.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1755945">
<id>Q14118</id>
</interactant>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1755945">
<id>Q14118</id>
</interactant>
<interactant intactId="EBI-2133962">
<id>Q3T1J5</id>
<label>Ank3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-20738807">
<id>PRO_0000021065</id>
</interactant>
<interactant intactId="EBI-20738802">
<id>PRO_0000021066</id>
<label>DAG1</label>
<dbReference type="UniProtKB" id="Q14118"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<molecule>Alpha-dystroglycan</molecule>
<subcellularLocation>
<location>Secreted</location>
<location>Extracellular space</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Beta-dystroglycan</molecule>
<subcellularLocation>
<location evidence="25">Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="25">Nucleus</location>
<location evidence="25">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cell membrane</location>
<location evidence="5">Sarcolemma</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cell junction</location>
<location evidence="5">Synapse</location>
<location evidence="5">Postsynaptic cell membrane</location>
</subcellularLocation>
<text evidence="5">The monomeric form translocates to the nucleus via the action of importins and depends on RAN. Nuclear transport is inhibited by Tyr-892 phosphorylation. In skeletal muscle, this phosphorylated form locates to a vesicular internal membrane compartment. In muscle cells, sarcolemma localization requires the presence of ANK2, while localization to costameres requires the presence of ANK3. Localizes to neuromuscular junctions (NMJs) in the presence of ANK2 (By similarity). In peripheral nerves, localizes to the Schwann cell membrane. Colocalizes with ERM proteins in Schwann-cell microvilli.</text>
</comment>
<comment type="tissue specificity">
<text evidence="19 42">Expressed in a variety of fetal and adult tissues. In epidermal tissue, located to the basement membrane. Also expressed in keratinocytes and fibroblasts.</text>
</comment>
<comment type="PTM">
<molecule>Alpha-dystroglycan</molecule>
<text evidence="6 15 21 23 24 27 29 30 33 34 36 39">O-glycosylated. POMGNT1 catalyzes the initial addition of N-acetylglucosamine, giving rise to the GlcNAc(beta1-2)Man(alpha1-)O-Ser/Thr moiety and thus providing the necessary basis for the addition of further carbohydrate moieties (PubMed:27493216). Heavily O-glycosylated comprising of up to two thirds of its mass and the carbohydrate composition differs depending on tissue type. Mucin-type O-glycosylation is important for ligand binding activity. O-mannosylation is found in high abundance in both brain and muscle where the most abundant glycan is Sia-alpha-2-3-Gal-beta-1-4-Glc-NAc-beta-1-2-Man. In muscle, glycosylation on Thr-317, Thr-319 and Thr-379 by a phosphorylated O-mannosyl glycan with the structure 2-(N-acetylamido)-2-deoxygalactosyl-beta-1,3-2-(N-acetylamido)-2-deoxyglucosyl-beta-1,4-6-phosphomannose is mediated by like-acetylglucosaminyltransferase (LARGE1) protein and is required for laminin binding (PubMed:20044576, PubMed:21987822, PubMed:24256719). The O-glycosyl hexose on Thr-367, Thr-369, Thr-372, Thr-381 and Thr-388 is probably mannose. O-glycosylated in the N-terminal region with a core 1 or possibly core 8 glycan. The brain form displays a unique glycosylation pattern which is absent in other tissues; this form shows enhanced binding to laminin LAMA5 compared to the skeletal muscle form (By similarity).</text>
</comment>
<comment type="PTM">
<molecule>Alpha-dystroglycan</molecule>
<text evidence="21 23">(Microbial infection) O-mannosylation is required for binding lymphocytic choriomeningitis virus, Old World Lassa fever virus, and clade C New World arenaviruses.</text>
</comment>
<comment type="PTM">
<molecule>Beta-dystroglycan</molecule>
<text evidence="25">N-glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="19 24 25 28">Autolytic cleavage produces the alpha and beta subunits. In cutaneous cells, as well as in certain pathological conditions, shedding of beta-dystroglycan can occur releasing a peptide of about 30 kDa.</text>
</comment>
<comment type="PTM">
<text>SRC-mediated phosphorylation of the PPXY motif of the beta subunit recruits SH2 domain-containing proteins, but inhibits binding to WWW domain-containing proteins, DMD and UTRN. This phosphorylation also inhibits nuclear entry.</text>
</comment>
<comment type="disease" evidence="32 37">
<disease id="DI-03074">
<name>Muscular dystrophy-dystroglycanopathy limb-girdle C9</name>
<acronym>MDDGC9</acronym>
<description>An autosomal recessive muscular dystrophy showing onset in early childhood, and associated with mental retardation without structural brain anomalies.</description>
<dbReference type="MIM" id="613818"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. MDDGC7 is caused by DAG1 mutations that interfere with normal post-translational processing, resulting in defective DAG1 glycosylation and impaired interactions with extracellular-matrix components. Other muscular dystrophy-dystroglycanopathies are caused by defects in enzymes involved in protein O-glycosylation.</text>
</comment>
<comment type="disease" evidence="35 38">
<disease id="DI-04533">
<name>Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A9</name>
<acronym>MDDGA9</acronym>
<description>An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound mental retardation, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.</description>
<dbReference type="MIM" id="616538"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Dystroglycan"/>
<text>Dystroglycan entry</text>
</comment>
<dbReference type="EMBL" id="L19711">
<property type="protein sequence ID" value="AAA81779.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291692">
<property type="protein sequence ID" value="BAF84381.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC104452">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW64989.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012740">
<property type="protein sequence ID" value="AAH12740.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014616">
<property type="protein sequence ID" value="AAH14616.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2799.1"/>
<dbReference type="PIR" id="I54343">
<property type="entry name" value="I54343"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001159400.2">
<property type="nucleotide sequence ID" value="NM_001165928.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171105.1">
<property type="nucleotide sequence ID" value="NM_001177634.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171106.1">
<property type="nucleotide sequence ID" value="NM_001177635.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171107.1">
<property type="nucleotide sequence ID" value="NM_001177636.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171108.1">
<property type="nucleotide sequence ID" value="NM_001177637.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171109.1">
<property type="nucleotide sequence ID" value="NM_001177638.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171110.1">
<property type="nucleotide sequence ID" value="NM_001177639.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171111.1">
<property type="nucleotide sequence ID" value="NM_001177640.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171112.1">
<property type="nucleotide sequence ID" value="NM_001177641.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171113.1">
<property type="nucleotide sequence ID" value="NM_001177642.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171114.1">
<property type="nucleotide sequence ID" value="NM_001177643.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001171115.1">
<property type="nucleotide sequence ID" value="NM_001177644.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004384.4">
<property type="nucleotide sequence ID" value="NM_004393.5"/>
</dbReference>
<dbReference type="PDB" id="1EG4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="P=881-895"/>
</dbReference>
<dbReference type="PDB" id="2MK7">
<property type="method" value="NMR"/>
<property type="chains" value="A=419-427"/>
</dbReference>
<dbReference type="PDB" id="5GGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="C/D=316-325"/>
</dbReference>
<dbReference type="PDB" id="5LLK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=52-315"/>
</dbReference>
<dbReference type="PDB" id="6JJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="U=877-895"/>
</dbReference>
<dbReference type="PDBsum" id="1EG4"/>
<dbReference type="PDBsum" id="2MK7"/>
<dbReference type="PDBsum" id="5GGP"/>
<dbReference type="PDBsum" id="5LLK"/>
<dbReference type="PDBsum" id="6JJY"/>
<dbReference type="SMR" id="Q14118"/>
<dbReference type="BioGRID" id="107975">
<property type="interactions" value="69"/>
</dbReference>
<dbReference type="CORUM" id="Q14118"/>
<dbReference type="DIP" id="DIP-40928N"/>
<dbReference type="IntAct" id="Q14118">
<property type="interactions" value="64"/>
</dbReference>
<dbReference type="MINT" id="Q14118"/>
<dbReference type="STRING" id="9606.ENSP00000442600"/>
<dbReference type="ChEMBL" id="CHEMBL3714399"/>
<dbReference type="MEROPS" id="S72.001"/>
<dbReference type="TCDB" id="9.B.277.1.1">
<property type="family name" value="the dystroglycan (dg) family"/>
</dbReference>
<dbReference type="GlyConnect" id="715">
<property type="glycosylation" value="9 N-Linked glycans (1 site), 1 O-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q14118">
<property type="glycosylation" value="19 sites, 1 N-linked glycan (1 site), 3 O-linked glycans (2 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q14118"/>
<dbReference type="PhosphoSitePlus" id="Q14118"/>
<dbReference type="SwissPalm" id="Q14118"/>
<dbReference type="UniCarbKB" id="Q14118"/>
<dbReference type="BioMuta" id="DAG1"/>
<dbReference type="DMDM" id="229462879"/>
<dbReference type="EPD" id="Q14118"/>
<dbReference type="jPOST" id="Q14118"/>
<dbReference type="MassIVE" id="Q14118"/>
<dbReference type="MaxQB" id="Q14118"/>
<dbReference type="PaxDb" id="Q14118"/>
<dbReference type="PeptideAtlas" id="Q14118"/>
<dbReference type="PRIDE" id="Q14118"/>
<dbReference type="ProteomicsDB" id="59825"/>
<dbReference type="TopDownProteomics" id="Q14118"/>
<dbReference type="Antibodypedia" id="4283">
<property type="antibodies" value="359 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1605"/>
<dbReference type="Ensembl" id="ENST00000308775">
<property type="protein sequence ID" value="ENSP00000312435"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000515359">
<property type="protein sequence ID" value="ENSP00000440705"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000538711">
<property type="protein sequence ID" value="ENSP00000438421"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000539901">
<property type="protein sequence ID" value="ENSP00000439334"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000541308">
<property type="protein sequence ID" value="ENSP00000440590"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000545947">
<property type="protein sequence ID" value="ENSP00000442600"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000673708">
<property type="protein sequence ID" value="ENSP00000501140"/>
<property type="gene ID" value="ENSG00000173402"/>
</dbReference>
<dbReference type="GeneID" id="1605"/>
<dbReference type="KEGG" id="hsa:1605"/>
<dbReference type="UCSC" id="uc003cxc.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1605"/>
<dbReference type="DisGeNET" id="1605"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000173402.11"/>
<dbReference type="GeneCards" id="DAG1"/>
<dbReference type="HGNC" id="HGNC:2666">
<property type="gene designation" value="DAG1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000173402">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="DAG1"/>
<dbReference type="MIM" id="128239">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613818">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616538">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14118"/>
<dbReference type="OpenTargets" id="ENSG00000173402"/>
<dbReference type="Orphanet" id="280333">
<property type="disease" value="Alpha-dystroglycan-related limb-girdle muscular dystrophy R16"/>
</dbReference>
<dbReference type="Orphanet" id="370997">
<property type="disease" value="Muscle-eye-brain disease with bilateral multicystic leucodystrophy"/>
</dbReference>
<dbReference type="Orphanet" id="899">
<property type="disease" value="Walker-Warburg syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA27138"/>
<dbReference type="eggNOG" id="KOG3781">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000008429"/>
<dbReference type="HOGENOM" id="CLU_007629_2_0_1"/>
<dbReference type="InParanoid" id="Q14118"/>
<dbReference type="KO" id="K06265"/>
<dbReference type="OMA" id="YDKEDTT"/>
<dbReference type="OrthoDB" id="163609at2759"/>
<dbReference type="PhylomeDB" id="Q14118"/>
<dbReference type="TreeFam" id="TF328370"/>
<dbReference type="PathwayCommons" id="Q14118"/>
<dbReference type="Reactome" id="R-HSA-3000171">
<property type="pathway name" value="Non-integrin membrane-ECM interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000178">
<property type="pathway name" value="ECM proteoglycans"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083628">
<property type="pathway name" value="Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083629">
<property type="pathway name" value="Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5083633">
<property type="pathway name" value="Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5173105">
<property type="pathway name" value="O-linked glycosylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9010553">
<property type="pathway name" value="Regulation of expression of SLITs and ROBOs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9619665">
<property type="pathway name" value="EGR2 and SOX10-mediated initiation of Schwann cell myelination"/>
</dbReference>
<dbReference type="SIGNOR" id="Q14118"/>
<dbReference type="BioGRID-ORCS" id="1605">
<property type="hits" value="6 hits in 881 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="DAG1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q14118"/>
<dbReference type="GeneWiki" id="Dystroglycan"/>
<dbReference type="GenomeRNAi" id="1605"/>
<dbReference type="Pharos" id="Q14118">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q14118"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q14118">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000173402">
<property type="expression patterns" value="Expressed in metanephric glomerulus and 258 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q14118">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14118">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005912">
<property type="term" value="C:adherens junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009925">
<property type="term" value="C:basal plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005604">
<property type="term" value="C:basement membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0062023">
<property type="term" value="C:collagen-containing extracellular matrix"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070938">
<property type="term" value="C:contractile ring"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043034">
<property type="term" value="C:costamere"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016011">
<property type="term" value="C:dystroglycan complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016010">
<property type="term" value="C:dystrophin-associated glycoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030175">
<property type="term" value="C:filopodium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098982">
<property type="term" value="C:GABA-ergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005796">
<property type="term" value="C:Golgi lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030027">
<property type="term" value="C:lamellipodium"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033268">
<property type="term" value="C:node of Ranvier"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034399">
<property type="term" value="C:nuclear periphery"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044853">
<property type="term" value="C:plasma membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099524">
<property type="term" value="C:postsynaptic cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0042383">
<property type="term" value="C:sarcolemma"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051393">
<property type="term" value="F:alpha-actinin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0002162">
<property type="term" value="F:dystroglycan binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043236">
<property type="term" value="F:laminin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043237">
<property type="term" value="F:laminin-1 binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042169">
<property type="term" value="F:SH2 domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008307">
<property type="term" value="F:structural constituent of muscle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015631">
<property type="term" value="F:tubulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017166">
<property type="term" value="F:vinculin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060055">
<property type="term" value="P:angiogenesis involved in wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031103">
<property type="term" value="P:axon regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071711">
<property type="term" value="P:basement membrane organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060445">
<property type="term" value="P:branching involved in salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016340">
<property type="term" value="P:calcium-dependent cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071397">
<property type="term" value="P:cellular response to cholesterol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071679">
<property type="term" value="P:commissural neuron axon guidance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060441">
<property type="term" value="P:epithelial tube branching involved in lung morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006509">
<property type="term" value="P:membrane protein ectodomain proteolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034453">
<property type="term" value="P:microtubule anchoring"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019048">
<property type="term" value="P:modulation by virus of host process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002011">
<property type="term" value="P:morphogenesis of an epithelial sheet"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002009">
<property type="term" value="P:morphogenesis of an epithelium"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016203">
<property type="term" value="P:muscle attachment"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0022011">
<property type="term" value="P:myelination in peripheral nervous system"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030336">
<property type="term" value="P:negative regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043409">
<property type="term" value="P:negative regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051898">
<property type="term" value="P:negative regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021675">
<property type="term" value="P:nerve development"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0021682">
<property type="term" value="P:nerve maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904261">
<property type="term" value="P:positive regulation of basement membrane assembly involved in embryonic body morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001954">
<property type="term" value="P:positive regulation of cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031643">
<property type="term" value="P:positive regulation of myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048714">
<property type="term" value="P:positive regulation of oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045860">
<property type="term" value="P:positive regulation of protein kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016476">
<property type="term" value="P:regulation of embryonic cell shape"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010717">
<property type="term" value="P:regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010470">
<property type="term" value="P:regulation of gastrulation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014894">
<property type="term" value="P:response to denervation involved in regulation of muscle adaptation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098942">
<property type="term" value="P:retrograde trans-synaptic signaling by trans-synaptic protein complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043403">
<property type="term" value="P:skeletal muscle tissue regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.70.1040">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00278"/>
<dbReference type="InterPro" id="IPR027468">
<property type="entry name" value="Alpha-dystroglycan_domain_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR041631">
<property type="entry name" value="Alpha_DG1_N2"/>
</dbReference>
<dbReference type="InterPro" id="IPR006644">
<property type="entry name" value="Cadg"/>
</dbReference>
<dbReference type="InterPro" id="IPR015919">
<property type="entry name" value="Cadherin-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR008465">
<property type="entry name" value="DAG1_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR030398">
<property type="entry name" value="SEA_DG_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF18424">
<property type="entry name" value="a_DG1_N2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05454">
<property type="entry name" value="DAG1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00736">
<property type="entry name" value="CADG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF111006">
<property type="entry name" value="SSF111006"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49313">
<property type="entry name" value="SSF49313"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51699">
<property type="entry name" value="SEA_DG"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0068">Autocatalytic cleavage</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0912">Congenital muscular dystrophy</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-1215">Dystroglycanopathy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0947">Limb-girdle muscular dystrophy</keyword>
<keyword id="KW-0451">Lissencephaly</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="9">
<location>
<begin position="1"/>
<end position="29"/>
</location>
</feature>
<feature type="chain" description="Alpha-dystroglycan" id="PRO_0000021065">
<location>
<begin position="30"/>
<end position="653"/>
</location>
</feature>
<feature type="chain" description="Beta-dystroglycan" id="PRO_0000021066">
<location>
<begin position="654"/>
<end position="895"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="9">
<location>
<begin position="654"/>
<end position="749"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="9">
<location>
<begin position="750"/>
<end position="775"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="9">
<location>
<begin position="776"/>
<end position="895"/>
</location>
</feature>
<feature type="domain" description="Peptidase S72">
<location>
<begin position="603"/>
<end position="712"/>
</location>
</feature>
<feature type="region of interest" description="Required for laminin recognition">
<location>
<begin position="30"/>
<end position="408"/>
</location>
</feature>
<feature type="region of interest" description="O-glycosylated at one site">
<location>
<begin position="169"/>
<end position="200"/>
</location>
</feature>
<feature type="region of interest" description="Mucin-like domain">
<location>
<begin position="316"/>
<end position="485"/>
</location>
</feature>
<feature type="region of interest" description="O-glycosylated at seven sites with GalNAc">
<location>
<begin position="463"/>
<end position="485"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with CAV3" evidence="12">
<location>
<begin position="819"/>
<end position="895"/>
</location>
</feature>
<feature type="region of interest" description="Required for binding DMD and UTRN">
<location>
<begin position="880"/>
<end position="895"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="31">
<location>
<begin position="776"/>
<end position="782"/>
</location>
</feature>
<feature type="short sequence motif" description="PPXY motif">
<location>
<begin position="889"/>
<end position="892"/>
</location>
</feature>
<feature type="compositionally biased region" description="Thr-rich">
<location>
<begin position="317"/>
<end position="484"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="809"/>
<end position="895"/>
</location>
</feature>
<feature type="site" description="Cleavage; by autolysis" evidence="24">
<location>
<begin position="653"/>
<end position="654"/>
</location>
</feature>
<feature type="site" description="Cleavage; by MMP9" evidence="28">
<location>
<begin position="715"/>
<end position="716"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3 4">
<location>
<position position="790"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="13 17 31">
<location>
<position position="892"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="34">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9">
<location>
<position position="141"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Man6P...) threonine" evidence="33 36">
<location>
<position position="317"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Man6P...) threonine" evidence="33 36">
<location>
<position position="319"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Hex...) threonine" evidence="30">
<location>
<position position="367"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Hex...) threonine" evidence="30">
<location>
<position position="369"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Hex...) threonine" evidence="30">
<location>
<position position="372"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Man6P...) threonine" evidence="29">
<location>
<position position="379"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Hex...) threonine" evidence="29">
<location>
<position position="381"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (Hex...) threonine" evidence="29">
<location>
<position position="388"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="30">
<location>
<position position="455"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9">
<location>
<position position="641"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9">
<location>
<position position="649"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="25">
<location>
<position position="661"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 40">
<location>
<begin position="182"/>
<end position="264"/>
</location>
</feature>
<feature type="disulfide bond" evidence="22">
<location>
<begin position="669"/>
<end position="713"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2131107." id="VAR_024335" evidence="18 20 42 44">
<original>S</original>
<variation>W</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In MDDGC9; no effect on dystroglycan expression; impairs alpha-dystroglycan glycosylation; dbSNP:rs189360006." id="VAR_075809" evidence="37">
<original>V</original>
<variation>I</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence variant" description="In MDDGC9; does not affect dystroglycan expression; impairs alpha-dystroglycan glycosylation; dbSNP:rs117209107." id="VAR_075810" evidence="37">
<original>D</original>
<variation>N</variation>
<location>
<position position="111"/>
</location>
</feature>
<feature type="sequence variant" description="In MDDGC9; results in impaired interaction with LARGE1 and incomplete DAG1 glycosylation; dbSNP:rs193922955." id="VAR_065266" evidence="32">
<original>T</original>
<variation>M</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In MDDGA9; dbSNP:rs797045023." id="VAR_075811" evidence="35">
<original>C</original>
<variation>F</variation>
<location>
<position position="669"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired laminin-binding." evidence="33 36">
<original>TPT</original>
<variation>APA</variation>
<location>
<begin position="317"/>
<end position="319"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect laminin-binding." evidence="33">
<original>TT</original>
<variation>AA</variation>
<location>
<begin position="328"/>
<end position="329"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoproteolysis and enhances laminin-binding." evidence="24 25">
<original>S</original>
<variation>A</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced N-linked glycosylation. No change in nuclear translocation." evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="663"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate reduction in nuclear accumulation.">
<original>RKKRKGK</original>
<variation>AKKRKGA</variation>
<location>
<begin position="776"/>
<end position="782"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 50% reduction in nuclear accumulation." evidence="31">
<original>KKRKGK</original>
<variation>AARKGA</variation>
<location>
<begin position="777"/>
<end position="782"/>
</location>
</feature>
<feature type="mutagenesis site" description="Drastic reduction in nuclear accumulation." evidence="31">
<original>KKRKGK</original>
<variation>RKKAAGA</variation>
<location>
<begin position="777"/>
<end position="782"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear translocation." evidence="25">
<original>KKRK</original>
<variation>NPGE</variation>
<location>
<begin position="777"/>
<end position="780"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant reduction in nuclear accumulation.">
<original>R</original>
<variation>A</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant reduction in nuclear accumulation.">
<original>K</original>
<variation>A</variation>
<location>
<position position="780"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear translocation." evidence="25">
<original>KK</original>
<variation>TA</variation>
<location>
<begin position="793"/>
<end position="794"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in nuclear location." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="823"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in nuclear location." evidence="25">
<original>PP</original>
<variation>AA</variation>
<location>
<begin position="828"/>
<end position="829"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in nuclear location." evidence="25">
<original>Y</original>
<variation>A</variation>
<location>
<position position="831"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation. No change in plasma membrane location." evidence="17 31">
<original>Y</original>
<variation>A</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="mutagenesis site" description="Redistributes to a vesicular internal membrane compartment." evidence="17 31">
<original>Y</original>
<variation>E</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation. Increase in nuclear location." evidence="17 31">
<original>Y</original>
<variation>F</variation>
<location>
<position position="892"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA81779." ref="1" evidence="45">
<original>E</original>
<variation>D</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA81779." ref="1" evidence="45">
<original>A</original>
<variation>P</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAF84381." ref="2" evidence="45">
<original>T</original>
<variation>A</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA81779." ref="1" evidence="45">
<original>A</original>
<variation>V</variation>
<location>
<position position="871"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="78"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="93"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="108"/>
<end position="111"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="112"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="116"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="123"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="127"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="144"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="188"/>
<end position="196"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="199"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="204"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="222"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="225"/>
<end position="229"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="241"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="256"/>
<end position="265"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="268"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="275"/>
<end position="283"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="285"/>
<end position="290"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="294"/>
<end position="302"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GGP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5LLK"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O18738"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q28685"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62165"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10767429"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10769203"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10988290"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11495720"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11724572"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12140558"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12592373"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12795607"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15175026"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16254364"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17212656"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17360738"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17905726"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18764929"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19324387"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19838169"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19946898"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20044576"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20507882"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20512930"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21388311"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21987822"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23234360"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24052401"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24256719"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25503980"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25934851"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27493216"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28781947"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7592992"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8268918"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9851927"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="45" type="ECO:0000305"/>
<sequence length="895" mass="97441" checksum="3AF6CBB0DCF91962" modified="2009-05-05" version="2" precursor="true">MRMSVGLSLLLPLSGRTFLLLLSVVMAQSHWPSEPSEAVRDWENQLEASMHSVLSDLHEAVPTVVGIPDGTAVVGRSFRVTIPTDLIASSGDIIKVSAAGKEALPSWLHWDSQSHTLEGLPLDTDKGVHYISVSATRLGANGSHIPQTSSVFSIEVYPEDHSELQSVRTASPDPGEVVSSACAADEPVTVLTVILDADLTKMTPKQRIDLLHRMRSFSEVELHNMKLVPVVNNRLFDMSAFMAGPGNAKKVVENGALLSWKLGCSLNQNSVPDIHGVEAPAREGAMSAQLGYPVVGWHIANKKPPLPKRVRRQIHATPTPVTAIGPPTTAIQEPPSRIVPTPTSPAIAPPTETMAPPVRDPVPGKPTVTIRTRGAIIQTPTLGPIQPTRVSEAGTTVPGQIRPTMTIPGYVEPTAVATPPTTTTKKPRVSTPKPATPSTDSTTTTTRRPTKKPRTPRPVPRVTTKVSITRLETASPPTRIRTTTSGVPRGGEPNQRPELKNHIDRVDAWVGTYFEVKIPSDTFYDHEDTTTDKLKLTLKLREQQLVGEKSWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDKGGLSAVDAFEIHVHRRPQGDRAPARFKAKFVGDPALVLNDIHKKIALVKKLAFAFGDRNCSTITLQNITRGSIVVEWTNNTLPLEPCPKEQIAGLSRRIAEDDGKPRPAFSNALEPDFKATSITVTGSGSCRHLQFIPVVPPRRVPSEAPPTEVPDRDPEKSSEDDVYLHTVIPAVVVAAILLIAGIIAMICYRKKRKGKLTLEDQATFIKKGVPIIFADELDDSKPPPSSSMPLILQEEKAPLPPPEYPNQSVPETTPLNQDTMGEYTPLRDEDPNAPPYQPPPPFTAPMEGKGSRPKNMTPYRSPPPYVPP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

